It has been demonstrated previously that gastric cancers that are negative for E-cadherin expression are more likely to be of poorly differentiated histology and also have higher rates of lymph node metastasis, peritoneal recurrence, and poorer survival outcomes [32]. Here, CDH1 is linked to metastatic malignant neoplasm in the lymph nodes.